Abstract
This study aims to estimate the impact of sugammadex administration as neuromuscular reversal agents on time spent in the operating room (OR) and post-acute care unit (PACU) and the potential economic impact of faster recovery in patients undergoing colectomy, hysterectomy, or bariatric surgery in France.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
